Most people with Parkinson's disease have idiopathic Parkinson's disease (having no specific known cause). A small proportion of cases, however, can be attributed to known genetic factors. Mutations in specific genes have been conclusively shown to cause PD. These genes code for alpha-synuclein (SNCA), parkin (PRKN), leucine-rich repeat kinase 2 (LRRK2 or dardarin), PTEN-induced putative kinase 1 (PINK1), DJ-1 and ATP13A2.[4][22] In most cases, people with these mutations will develop PD. With the exception of LRRK2, however, they account for only a small minority of cases of PD.[4] The most extensively studied PD-related genes are SNCA and LRRK2. Mutations in genes including SNCA, LRRK2 and glucocerebrosidase (GBA) have been found to be risk factors for sporadic PD. The role of the SNCA gene is important in PD because the alpha-synuclein protein is the main component of Lewy bodies.[22] Missense mutations of the gene (in which a single nucleotide is changed), and duplications and triplications of the locus containing it have been found in different groups with familial PD. Mutations in LRRK2 are the most common known cause of familial and sporadic PD, accounting for approximately 5% of individuals with a family history of the disease and 3% of sporadic cases.
Sources: [http://en.wikipedia.org/wiki/Parkinson's_disease wikipedia], [https://www.qiagen.com/geneglobe/pathwayview.aspx?pathwayID=345 Qiagen], and [http://www.genome.jp/kegg/pathway/hsa/hsa05012.html KEGG].
Proteins on this pathway have targeted assays available via the [https://assays.cancer.gov/available_assays?wp_id=WP2371 CPTAC Assay Portal]cffbc1a5cc3cfe0dd8dd9a6ac51ba3Aggregation of misfolded mutantc56c0ac36b80e5daggretion of misfolded mutatantfa2O-glycosylationea0c51Aggregation of misfolded mutant15503154PubMedCauses of Parkinson's disease: genetics of DJ-1.Cell Tissue Res2004Abou-Sleiman PMHealy DGWood NW20371350PubMedTranscriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP.Cell2010Hafner MLandthaler MBurger LKhorshid MHausser JBerninger PRothballer AAscano M JrJungkamp ACMunschauer MUlrich AWardle GSDewell SZavolan MTuschl T12628165PubMedParkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity.Neuron2003Staropoli JFMcDermott CMartinat CSchulman BDemireva EAbeliovich Adisease pathwayPW:0000013Pathway Ontology20584986PubMedmiR-375 inhibits differentiation of neurites by lowering HuD levels.Mol Cell Biol2010Abdelmohsen KHutchison ERLee EKKuwano YKim MMMasuda KSrikantan SSubaran SSMarasa BSMattson MPGorospe M15896322PubMedCommon anti-apoptotic roles of parkin and alpha-synuclein in human dopaminergic cells.Biochem Biophys Res Commun2005Machida YChiba TTakayanagi ATanaka YAsanuma MOgawa NKoyama AIwatsubo TIto SJansen PHShimizu NTanaka KMizuno YHattori N19956200PubMedInduction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation.Leukemia2010Forrest ARKanamori-Katayama MTomaru YLassmann TNinomiya NTakahashi Yde Hoon MJKubosaki AKaiho ASuzuki MYasuda JKawai JHayashizaki YHume DASuzuki H12728264PubMedTargeting programmed cell death in neurodegenerative diseases.Nat Rev Neurosci2003Vila MPrzedborski S19088304PubMedMicroRNA target prediction by expression analysis of host genes.Genome Res2009Gennarino VASardiello MAvellino RMeola NMaselli VAnand SCutillo LBallabio ABanfi S15651302PubMed[The gene products for familial Parkinson's disease provide us hints to elucidate the mechanisms of nigral degeneration].Rinsho Shinkeigaku2004Hattori NParkinson disease pathwayPW:0000018Pathway Ontology16022590PubMedMolecular pathophysiology of Parkinson's disease.Annu Rev Neurosci2005Moore DJWest ABDawson VLDawson TM12783850PubMedThe p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration.Hum Mol Genet2003Corti OHampe CKoutnikova HDarios FJacquier SPrigent ARobinson JCPradier LRuberg MMirande MHirsch ERooney TFournier ABrice ALewy body dementiaDOID:12217Disease16495942PubMedExpanding insights of mitochondrial dysfunction in Parkinson's disease.Nat Rev Neurosci2006Abou-Sleiman PMMuqit MMWood NW15054086PubMedDoes alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse?FASEB J2004Sidhu AWersinger CVernier P15505146PubMedWhat does PINK1 mean for Parkinson diseases?Neurology2004Singleton Aneurodegenerative diseaseDOID:1289Disease17911161PubMedParkinson's disease.Hum Mol Genet2007Thomas BBeal MFParkinson's diseaseDOID:14330Disease23383003PubMedMicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1.PLoS One2013Hui WYuntao LLun LWenSheng LChaoFeng LHaiYong HYueyang B18426756PubMedProgress in the pathogenesis and genetics of Parkinson's disease.Philos Trans R Soc Lond B Biol Sci2008Mizuno YHattori NKubo SSato SNishioka KHatano TTomiyama HFunayama MMachida YMochizuki H15952880PubMedThe biochemistry of Parkinson's disease.Annu Rev Biochem2005Cookson MR15229644PubMedHow does parkin ligate ubiquitin to Parkinson's disease?EMBO Rep2004Kahle PJHaass Cneurodegenerative disease pathwayPW:0000014Pathway Ontology19461653PubMedThe miR-34 family in cancer and apoptosis.Cell Death Differ2010Hermeking H24797360PubMedProfiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology.PLoS One201424797360PubMedProfiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology.PLoS One2014Burgos KMalenica IMetpally RCourtright ARakela BBeach TShill HAdler CSabbagh MVilla STembe WCraig DVan Keuren-Jensen K19524505PubMedTherapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model.Cell2009Kota JChivukula RRO'Donnell KAWentzel EAMontgomery CLHwang HWChang TCVivekanandan PTorbenson MClark KRMendell JRMendell JT18680555PubMedMitochondrial alterations in Parkinson's disease: new clues.J Neurochem2008Vila MRamonet DPerier C12716939PubMedParkin binds to alpha/beta tubulin and increases their ubiquitination and degradation.J Neurosci2003Ren YZhao JFeng Jdopaminergic neuronCL:0000700Cell Type